Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Milestone Pharmaceuticals Inc (NQ: MIST )

1.760 +0.010 (+0.57%)
Streaming Delayed Price Updated: 10:07 AM EDT, May 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Milestone Pharmaceuticals Inc

< Previous 1 2 Next >
Milestone Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
Milestone Pharmaceuticals's Return On Capital Employed Overview
Via Benzinga
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
Milestone Pharma Stock Surges After Successful Trial For Abnormal Heart Rhythm Candidate
Via Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Acorda Therapeutics (NASDAQ:ACOR) shares increased by 46.1% to $0.49 during Monday's pre-market session. The company's market cap stands at $11.9 million. 
Via Benzinga
Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Good morning, investor! It's time to start off the trading week with a breakdown of the biggest pre-market stock movers on Monday! 
Via InvestorPlace
Recap: Milestone Pharmaceuticals Q2 Earnings
  Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. 
Via Benzinga
Milestone Pharmaceuticals: Q1 Earnings Insights
Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2022
Upgrades 
Via Benzinga
Milestone Pharmaceuticals: Q4 Earnings Insights
Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:20 AM. Here's what investors need to know about the... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 54 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week... 
Via Benzinga
70 Biggest Movers From Yesterday
Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Opiant Pharmaceuticals (NASDAQ:OPNT 
Via Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at... 
Via Benzinga
Exposures Product Safety
Week In Review: LianBio Acquires Two IBD Candidates In $218 Million Deal
LianBio, a Princeton-Shanghai company, in-licensed Greater China rights for two inflammatory bowel disease candidates from Landos Biopharma. The $218 million deal includes $18 million upfront and $200... 
Via Talk Markets
Milestone Pharma-Ji Xing Pharma Ink $127M Etripamil Development Agreement For China
Milestone Pharmaceuticals Inc (NASDAQ: MIST) hit a major snag last March when its investigational etripamil nasal spray for episodes of rapid heart rate missed the... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) shares increased by 20.68% to $1.4 during Monday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.